ストックスクリーナーアプリを入手
93.48
0.51%
0.475
前日終値:
$93.01
開ける：
$93.01
24時間の取引高:
7.31M
Relative Volume:
0.16
時価総額：
$119.58B
収益：
$36.36B
当期純損益:
$4.84B
株価収益率:
25.09
EPS:
3.7261
ネットキャッシュフロー:
$5.43B
1週間 パフォーマンス:
+9.33%
1か月 パフォーマンス:
-0.34%
6か月 パフォーマンス:
+6.09%
1年 パフォーマンス:
-3.16%
1日の値動き範囲:
$92.16
$93.53
1週間の範囲:
$85.55
$93.01
52週間の値動き範囲:
$73.31
$106.33
Medtronic Plc Stock (MDT) Company Profile
名前
Medtronic Plc
セクター
電話
01135314381700
住所
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
93.48 | 119.58B | 36.36B | 4.84B | 5.43B | 3.7261 |
ABT
Abbott Laboratories
|
102.70 | 177.71B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
281.36 | 107.92B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.73 | 61.93B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.89 | 49.51B | 6.30B | 1.07B | 1.09B | 1.8406 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-10-07 | 開始されました | Barclays | Equal Weight |
| 2026-08-27 | 繰り返されました | Needham | Buy |
| 2026-07-28 | アップグレード | UBS | Neutral → Buy |
| 2026-06-04 | アップグレード | BTIG Research | Neutral → Buy |
| 2026-05-21 | 再開されました | Goldman | Neutral |
| 2026-02-13 | 再開されました | Barclays | Overweight |
| 2026-02-09 | アップグレード | Needham | Hold → Buy |
| 2026-02-03 | 再開されました | Citigroup | Buy |
| 2026-01-30 | 再開されました | Wells Fargo | Overweight |
| 2026-01-06 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-11-19 | アップグレード | Goldman | Sell → Neutral |
| 2025-06-30 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | 開始されました | Leerink Partners | Outperform |
| 2025-03-04 | アップグレード | Citigroup | Neutral → Buy |
| 2024-10-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 繰り返されました | Oppenheimer | Perform |
| 2024-08-15 | アップグレード | UBS | Sell → Neutral |
| 2024-08-14 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | ダウングレード | UBS | Buy → Sell |
| 2023-01-09 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-11-23 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-11-16 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-08-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-06-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | ダウングレード | Needham | Buy → Hold |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-12-16 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-10 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-12-15 | アップグレード | Goldman | Sell → Neutral |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | アップグレード | Stifel | Hold → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-05-14 | ダウングレード | DZ Bank | Buy → Hold |
| 2020-03-30 | ダウングレード | Needham | Strong Buy → Buy |
| 2020-03-25 | アップグレード | DZ Bank | Hold → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Sell |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2020-01-02 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-06-05 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 繰り返されました | Needham | Strong Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-12-19 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-27 | 繰り返されました | Argus | Buy |
すべてを表示
Medtronic Plc (MDT) 最新ニュース
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know - Zacks Investment Research
Abbott Laboratories vs. Intuitive Surgical: Which Healthcare Stock Is a Better Buy in 2026? - The Motley Fool
4 Healthcare Stocks Worth Owning for the Next Decade - The Motley Fool
How Investors Are Reacting To Medtronic (MDT) Advancing Altaviva, Symplicity Spyral And Spinning Off MiniMed - Yahoo Finance
Barclays starts coverage with USD 95 target for Medtronic stock - AD HOC NEWS
Medtronic (MDT) Commits $700 Million To Robotics As 2026 Impact Report Lands - Yahoo Finance
China Airway Management Market Forecast to 2033Airway Management Tubes and Intubation Accessories | Revenue, Volume, Pricing, Company Share, and Growth Opportunities - GlobeNewswire Inc.
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Medtronic options flow points to volatility bet with bullish overlay near $90 - Investing.com
Gradient Investments LLC Sells 43,675 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic Rises as MiniMed Split-Off Exchange Ratio Nears Completion - Quiver Quantitative
Up to 225M MiniMed shares are on offer as Medtronic (MDT) sets the final exchange ratio. - Stock Titan
Barclays Upgrades Medtronic (NYSE:MDT) to "Hold" - MarketBeat
[425] Medtronic plc Business Combination Communication - Stock Titan
Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc. - PR Newswire
Medtronic PLC stock underperforms Wednesday when compared to competitors - MarketWatch
12,237 Shares of Medtronic PLC $MDT Bought by Worth Asset Management LLC - MarketBeat
Medtronic : Receives FDA Clearance for ApexCutTM EM Navigated Blades for Sinus Surgery - www.marketscreener.com
The "Trumpflation" Trade Could Get Worse Before It Gets Better. History Says These 2 Stocks Are the Place to Hide. - The Motley Fool
883,081 Shares in Medtronic PLC $MDT Purchased by Congress Asset Management Co. - MarketBeat
Medtronic : Presents New Nocturia Data for the AltavivaTM Device, Announces National Principal Investigator for the ENDURANCE Study - www.marketscreener.com
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
Medtronic PLC stock underperforms Tuesday when compared to competitors - MarketWatch
Medtronic (NYSE:MDT) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Medtronic Impact Report Highlights More Than 82 Million Patients Served Worldwide in Fiscal Year 2026 - CSRwire
Global Bioelectronic Medicine Market Anticipates Impressive Growth Trajectory of ~10% by 2034 | DelveInsight - GlobeNewswire Inc.
Can J&J's MedTech Business Rebound in Q3 After Q2 Slowdown? - Zacks Investment Research
Medtronic (MDT) Outperforms Broader Market: What You Need to Know - Zacks Investment Research
Medtronic (MDT) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Medtronic PLC stock outperforms competitors on strong trading day - MarketWatch
Why I Think These Are the 2 Smartest Stocks to Buy With $5,000 in October - The Motley Fool
13,988 Medtronic PLC $MDT Shares Sold by Park National Corp OH - MarketBeat
Jim Cramer Likes Medtronic (MDT) at 14x Earnings — So Why Isn’t He Buying More? - Yahoo Finance
Medtronic PLC $MDT Shares Acquired by MassMutual Private Wealth & Trust FSB - MarketBeat
2 High-Yield Stocks to Buy in October Without Any Hesitation - The Motley Fool
CX Institutional Sells 86,818 Shares of Medtronic PLC $MDT - MarketBeat
Wall Street Is Bracing for the Fed's Next Move on Rates. These 3 Stocks Win Either Way. - The Motley Fool
Medtronic Has Been Boring Investors for Years. That Could Be Changing - Yahoo Finance
[425] Medtronic plc Business Combination Communication - Stock Titan
Can ISRG Offset China Weakness With Expansion in India and Japan? - Zacks Investment Research
Is Medtronic (MDT) Reasonable On Cash Flow After Its $700 Million Robotics Bet? - Simply Wall Street
[425] Medtronic plc Business Combination Communication - Stock Titan
AMA approves permanent CPT codes for Medtronic's devices treating urinary incontinence and hypertension. - Pluang
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems - Medtronic
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems - PR Newswire
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems - Stock Titan
Medtronic options flow dominated by large December put spread - Investing.com
Confluence Investment Management LLC Cuts Position in Medtronic PLC $MDT - MarketBeat
Medtronic Sees Unusually High Options Volume (NYSE:MDT) - MarketBeat
Medtronic drug-coated balloon gets FDA breakthrough status - MedTech Dive
Medtronic Plc (MDT) 財務データ
収益
当期純利益
現金流量
EPS
Medtronic Plc (MDT) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| KIIL HARRY SKIP | Officer |
Sep 16 '26 |
Proposed Sale |
93.65 |
1,483 |
138,889 |
0 |
| Walter Matthew R. | SVP, Chief HR Officer |
Jul 08 '26 |
Sale |
83.15 |
3,102 |
257,931 |
35,694 |
| Walter Matthew R. | Officer |
Jul 08 '26 |
Proposed Sale |
83.15 |
3,102 |
257,931 |
0 |
| KIIL HARRY SKIP | EVP & President Cardiovascular |
Jun 08 '26 |
Sale |
80.44 |
4,189 |
336,965 |
37,227 |
| KIIL HARRY SKIP | Officer |
Jun 08 '26 |
Proposed Sale |
80.44 |
4,189 |
336,965 |
0 |
| Blomquist Denise L. | Chief Accounting Officer |
May 26 '26 |
Option Exercise |
0.00 |
1,712 |
0 |
14,974 |
| KIIL HARRY SKIP | EVP & President Cardiovascular |
May 26 '26 |
Option Exercise |
0.00 |
15,195 |
0 |
48,233 |
| Walter Matthew R. | SVP, Chief HR Officer |
May 26 '26 |
Option Exercise |
0.00 |
9,149 |
0 |
41,529 |
| Wall Brett A. | EVP & Pres Neuroscience |
May 26 '26 |
Option Exercise |
0.00 |
26,907 |
0 |
82,183 |
| Martha Geoffrey | Chairman and CEO |
May 26 '26 |
Option Exercise |
0.00 |
94,963 |
0 |
343,099 |
0.43%
0.11%
大文字化:
|
ボリューム (24 時間):